Kaiser Permanente
Portland, Oregon 97232
0 studies enrolling now · 21 studies all time
What they study most
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Anaplastic Large-Cell Lymphoma, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Bronchitis, Chronic Graft Versus Host Disease, Chronic Lymphocytic Leukemia, Chronic Obstructive Pulmonary Disease Severe, Diffuse Large B-cell Lymphoma, End Stage Renal Disease, Estrogen Receptor Positive Breast Cancer
Studies at this site
- A Long-term Extension Study of PCI-32765 (Ibrutinib) — Recruiting now
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer — Completed
- Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial — Completed
- A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
- Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer — Completed
- A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) — Completed
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery — Completed
- Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis — Completed
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
- A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) — Completed
- Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer — Stopped early
- S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer — Stopped early
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Completed
- To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen — Completed
- Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery — Completed
- Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma — Completed
- Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma — Completed
- FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma — Completed
- Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) — Completed